The Holidays are upon us and many families will be without their beloved child. Please consider making a year-end donation or sponsoring our
Night of Hope Gala on January 18, 2011 at the J Restaurant & Lounge in Los Angeles as we honor all those babies that are fighting for their lives and those that have earned their angel wings.
Repeat Possessions will be at The Hope for SMA Gala and we would love for you to join us!
If you are not able to attend, please consider making a tax deductible donation or use code SMA at Repeat Possessions checkout for free shipping and we will make a 10% donation to Sophias Cure Foundation.
Spinal Muscular Atrophy (SMA) is the leading genetic killer of infants and young children. It is a terminal, degenerative disease that results in the loss of nerves in the spinal cord and the weakness of the muscles connected with those nerves. SMA impacts the ability to walk, stand, sit, eat, breathe and even swallow. The mind and spirit are no different from that of a healthy baby, but the body eventually fails. Typical babies with SMA Type 1 have a life expectancy of between one and two years and they require around-the-clock medical assistance and monitoring.
• SMA is the #1 genetic killer of infants and young children
• 1 in every 40 people or nearly 10 million Americans UNKNOWINGLY carry the gene responsible for SMA
• 1 in 6,000 babies are effected every year.
• SMA is does not discriminate based on race, ethnicity, or gender
There is currently no treatment and no cure, but the National Institutes of Health (NIH) and the National Institute of Neurological Disorders and Stroke (NINDS) selected SMA as the disease closest to treatment of more than 600 neurological disorders.
Researchers estimate that we are as close as only a few years away from finding a treatment and/or cure.
As a child with SMA grows their bodies are doubly stressed, first by the decrease in motor neurons and then by the increased demands on the nerve and muscle cells as their bodies grow larger. The resulting muscle atrophy can cause weakness and bone and spinal deformities that may lead to further loss of function, as well as additional compromise of the respiratory (breathing) system.
SMA is an autosomal recessive genetic disease. In order for a child to be affected by SMA, both parents must be carriers of the abnormal gene and both must pass this gene on to their child. Although both parents are carriers the likelihood of a child inheriting the disorder is 25%, or 1 in 4.